AirXpanders Status
The company received AUD 20 million of development capital from undisclosed investors on June 8, 2016. The funding will be primarily used by the Company for Market growth of AeroForm in Australia; Sales and marketing investment in preparation for U.S. launch of Aeroform®, targeted for 1QCY2017 (subject to receipt of FDA clearance); Completion of commercial manufacturing transfer to Costa Rica; and General working capital. Previously, the company raised AUD 36.5 million in its initial public offering on the Australian stock exchange under the ticker symbol of AXP on June 19, 2015.
Add a review